We are here to assist you.
Health Advisor
+91-8877772277Available 7 days a week
10:00 AM – 6:00 PM to support you with urgent concerns and guide you toward the right care.
Explore ovarian cancer screening, including CA-125 tests and ultrasounds. Understand risk factors, symptoms, and when to consult a doctor.

Ovarian cancer. The very words can send a shiver down the spine. It's a formidable adversary, often called the 'silent killer' among gynecological cancers, and for good reason. It often creeps in without a whisper, making its presence known only when it has advanced. This stealthy nature is precisely why understanding screening, even when it's not universally recommended, is so vital. Especially for us here in India, where awareness and access to advanced diagnostics can sometimes be a challenge, arming ourselves with knowledge is our first line of defense.
Let's be clear from the outset: the U.S. Preventive Services Task Force (USPSTF), a leading authority, does not currently recommend routine ovarian cancer screening for individuals who have no symptoms and no increased risk factors. This might sound a bit unsettling, but there are reasons behind this. Screening tests, while promising, aren't perfect. They can sometimes flag issues that aren't there (false positives), leading to unnecessary anxiety, further invasive tests, and even treatments that aren't needed. Imagine going through a battery of tests, feeling unwell, only to find out it was a false alarm. It's a real concern.
However, 'not recommended for everyone' doesn't mean 'never.' For those of us with a reason to be more vigilant – perhaps a history of ovarian or breast cancer in the family, or experiencing unusual symptoms – the conversation about screening becomes incredibly important. This is where proactive health management truly shines. Your health journey is unique, and what's right for one person might not be right for another. That's why a personalized approach, guided by a trusted doctor, is paramount.
This guide aims to demystify ovarian cancer screening. We'll explore the tests available, who might benefit from them, and most importantly, how you can have an informed discussion with your healthcare provider. We want to empower you with the facts, helping you navigate this complex topic with confidence and peace of mind.
Ovarian cancer is a serious concern, being the most lethal form of gynecological cancer. Its danger lies in its often asymptomatic early stages. Unlike some other cancers where early symptoms might be more obvious, ovarian cancer can quietly progress. By the time symptoms do appear, the cancer may have already spread, making treatment more challenging. This is why, even without universal screening, understanding potential risks and signs is essential.
The risk of developing ovarian cancer does increase with age. Statistics show that a significant portion of diagnoses occur in women aged 63 and older. Furthermore, a strong family history, particularly of ovarian or breast cancer, significantly elevates risk. This genetic predisposition is a key factor that doctors consider when evaluating the need for screening.
When we talk about screening for ovarian cancer, a few key tests come into play. It's important to understand what they are and what they can and cannot tell us.
This test measures the level of a protein called CA-125 (Cancer Antigen 125) in your blood. In many cases of ovarian cancer, CA-125 levels are elevated. We're talking about roughly 80% of women with later-stage ovarian cancer and about 50% with early-stage disease showing higher levels. However, and this is a big 'however,' elevated CA-125 levels are not exclusive to ovarian cancer. They can also be raised due to other conditions like endometriosis, uterine fibroids, pelvic inflammatory disease, and even pregnancy. This is why the CA-125 test alone cannot diagnose ovarian cancer. It's more often used after a diagnosis to help determine the stage of the cancer and to monitor how well treatment is working.
What if my CA-125 is high? A high CA-125 reading warrants further investigation by your doctor. It doesn't automatically mean you have cancer, but it signals that something needs closer examination. Your doctor will consider your symptoms, medical history, and potentially other tests to figure out the cause.
Cost consideration: If you're looking at the cost outside of insurance, a CA-125 test can average around $92. Insurance and Medicare often cover this test when deemed medically necessary, with reimbursement rates typically between $31 to $36. Interestingly, some direct-to-consumer kits are advertised for as low as $18, but these should be approached with caution and discussed with a healthcare professional.
This imaging test uses sound waves to create pictures of the pelvic organs, including the ovaries. A small, wand-like device is inserted into the vagina, allowing for a close-up view. It can help identify any abnormalities in the size, shape, or structure of the ovaries, such as cysts or masses. A transvaginal ultrasound can cost anywhere from $108 to $375, and like the CA-125 test, it's often covered by Medicare and most insurance plans when recommended by a doctor.
It's crucial to reiterate that neither the CA-125 test nor the transvaginal ultrasound is perfect for screening the general population. The USPSTF, for instance, recommends using the CA-125 test alongside other methods *only* for individuals who are experiencing symptoms or are at high risk. Relying on these tests in isolation for everyone could lead to a significant number of false positives. This means people might undergo further, potentially invasive, and anxiety-inducing procedures based on a test result that doesn't actually indicate cancer.
If you're wondering whether you fall into a higher-risk category, here are the key considerations:
Because routine screening isn't advised for everyone, being aware of the potential symptoms of ovarian cancer is your next best line of defense. The tricky part is that these symptoms can often be vague and mimic other, less serious conditions. However, if you experience any of the following, especially if they are new, persistent (lasting more than two weeks), or come on suddenly, it's time to consult a doctor:
Remember, these symptoms can be caused by many things. The key is persistence and a change from your normal. Don't dismiss them!
It's important to address that ovarian cancer is not solely a
This section adds practical context and preventive advice to help readers make informed healthcare decisions. It is important to verify symptoms early, consult qualified doctors, and avoid self-medication for persistent health issues.
Maintaining healthy routines, following prescribed treatment plans, and attending regular checkups can improve outcomes. If symptoms worsen or red-flag signs appear, immediate medical evaluation is recommended.
Track symptoms and duration.
Follow diagnosis and treatment from a licensed practitioner.
Review medication side effects with your doctor.
Seek urgent care for severe warning signs.
Learn about potential side effects of CML treatments like TKIs, interferon, chemotherapy, and stem cell transplants. Understand what to expect and how to communicate with your doctor for effective management.
April 1, 2026

Discover essential support resources, financial aid options, and community connections for individuals navigating life with Chronic Myeloid Leukemia (CML). Find practical advice and empathetic guidance.
April 1, 2026
Explore targeted therapy for multiple myeloma. Learn how these precision treatments work, their types, potential side effects, and how they're used alongside other therapies to manage this blood cancer.
April 1, 2026